Side-by-side comparison of AI visibility scores, market position, and capabilities
Ataccama is an enterprise data quality and governance platform combining AI-powered data profiling, master data management, and catalog capabilities in a unified product.
Ataccama is an enterprise data quality and governance platform that combines AI-powered data profiling and quality management, master data management, and data catalog capabilities into a unified product designed to address the full set of data trustworthiness challenges that organizations face when building analytics and operational data programs on unreliable data foundations. The platform's data quality engine profiles data assets automatically upon connection, identifying data type anomalies, pattern violations, null rates, referential integrity failures, and statistical outliers that indicate data quality issues, and then allows data quality teams to define business rules and threshold-based quality checks that run continuously against connected data sources to detect quality degradation in production data pipelines. This combination of automated profiling and rules-based monitoring provides both discovery of existing quality problems and ongoing detection of new issues introduced by upstream data changes.
Adept AI raised $415M to pioneer computer-use AI agents; its core research and agent team moved to Amazon in 2024 in a landmark talent acquisition while the company continues developing ACT-1 for enterprise automation.
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and executing multi-step workflows in any application. Its ACT-1 model demonstrated the ability to control web browsers and desktop applications through natural language instructions, pioneering the computer-use agent paradigm that Anthropic later commercialized with Claude's computer use feature.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.